Related Experiment Video
Updated: Sep 26, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Adult bacteremic pneumococcal pneumonia acquired in the community. A prospective study on 101 patients
Jorge H Gentile1, Mónica D Sparo, María E Mercapide
1Servicio de Infectología, Laboratorio de Microbiología, Hospital R. Santamarina, Tandil. jorgeg@poraire.net.ar
Abstract:
Our objective was to describe incidence, clinical, radiographic and microbiological features of bacteremic pneumococcal pneumonia (BPP) in our environment. A total of 101 patients (7 were treated as outpatients), older than 18 years of age suffering BPP were prospectively evaluated. The incidence was 2.8 cases per 1000 admissions, 50 were males, mean age was 59.9 years (19-97), mortality was 11.8%. Eighty three percent of fatalities occurred within 3 days of admission. Mortality rate increased with advancing age. Fever, cough and chest pain were the commonest presenting symptoms and 44% of patients had extrapulmonary manifestations. Cigarette smoking, chronic obstructive lung disease, alcoholism and congestive heart failure (CHF) were the commonest underlying conditions. CHF was more frequent in non-survivors (p = 0.002). A lobar pattern at chest radiograph predominated in survivors and a diffuse pattern in non-survivors (p = 0.007). Pleural effusion (20.7%), empyema (7.9%) and respiratory failure (7.9%) were the main complications. Underlying diseases were present in 100% of non-survivors (p = 0.03). Ninety four percent of patients were treated with beta-lactam antibiotics. Streptococcus pneumoniae was isolated from sputum in 6 cases. Three out of 101 S. pneumoniae isolates recovered from blood samples (one from each patient) presented organisms resistant to penicillin. We observed an incidence of BPP that is similar to the observed in other countries. There are clinical and radiographic differences between survivors and non-survivors. Penicillin-resistant S. pneumoniae is still an unusual problem in our area.
Insights
Bacteremic pneumococcal pneumonia (BPP) affects adults, with higher mortality in older patients and those with heart failure. Penicillin-resistant Streptococcus pneumoniae remains uncommon in this setting.
Area of Science:
- Infectious Diseases
- Pulmonology
- Microbiology
Background:
- Bacteremic pneumococcal pneumonia (BPP) is a significant cause of morbidity and mortality.
- Understanding its epidemiological and clinical features is crucial for effective management.
Purpose of the Study:
- To describe the incidence, clinical, radiographic, and microbiological characteristics of BPP.
- To identify factors associated with mortality in BPP patients.
Main Methods:
- Prospective evaluation of 101 adult patients with BPP.
- Data collection included demographics, clinical presentation, radiographic findings, microbiological results, and outcomes.
- Statistical analysis to compare survivors and non-survivors.
Main Results:
- Incidence of BPP was 2.8 cases per 1000 admissions.
- Common symptoms included fever, cough, and chest pain; 44% had extrapulmonary manifestations.
- Mortality was 11.8%, increasing with age. Congestive heart failure (CHF) was more frequent in non-survivors.
- Lobar radiographic patterns were seen in survivors, diffuse patterns in non-survivors.
- Penicillin-resistant Streptococcus pneumoniae was rare (3%).
Conclusions:
- BPP incidence is comparable to international data.
- Clinical and radiographic differences exist between survivors and non-survivors.
- Penicillin resistance in S. pneumoniae is currently an infrequent issue in this region.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia
Pneumonia III: Complications and Assessment
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology

